Russell J. Cox

2013 - Jazz Pharmaceuticals

In 2013, Russell J. Cox earned a total compensation of $2.4M as Executive Vice President and Chief Operating Officer at Jazz Pharmaceuticals, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$380,000
Option Awards$765,325
Salary$419,616
Stock Awards$813,038
Other$3,622
Total$2,381,601

Cox received $813K in stock awards, accounting for 34% of the total pay in 2013.

Cox also received $380K in non-equity incentive plan, $765.3K in option awards, $419.6K in salary and $3.6K in other compensation.

Rankings

In 2013, Russell J. Cox's compensation ranked 3,281st out of 12,286 executives tracked by ExecPay. In other words, Cox earned more than 73.3% of executives.

ClassificationRankingPercentile
All
3,281
out of 12,286
73rd
Division
Manufacturing
1,111
out of 4,612
76th
Major group
Chemicals And Allied Products
291
out of 1,466
80th
Industry group
Drugs
198
out of 1,160
83rd
Industry
Pharmaceutical Preparations
165
out of 890
82nd
Source: SEC filing on June 20, 2016.

Cox's colleagues

We found four more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2013.

2013

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2013

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2013

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2013

Fintan Keegan

Jazz Pharmaceuticals

Executive Vice President, Technical Operations

News

You may also like